rhazinilam has been researched along with 3-ethylpyridine in 1 studies
| Studies (rhazinilam) | Trials (rhazinilam) | Recent Studies (post-2010) (rhazinilam) | Studies (3-ethylpyridine) | Trials (3-ethylpyridine) | Recent Studies (post-2010) (3-ethylpyridine) |
|---|---|---|---|---|---|
| 34 | 0 | 13 | 11 | 0 | 4 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kam, TS; Lim, JL; Lim, SH; Loong, BJ; Low, YY; Sim, KS; Ting, KN; Yong, KT | 1 |
1 other study(ies) available for rhazinilam and 3-ethylpyridine
| Article | Year |
|---|---|
Biologically active vallesamine, strychnan, and rhazinilam alkaloids from Alstonia: Pneumatophorine, a nor-secovallesamine with unusual incorporation of a 3-ethylpyridine moiety.
Topics: Aldehydes; Alkaloids; Alstonia; Animals; Antineoplastic Agents, Phytogenic; Aorta; Carbazoles; Cell Line, Tumor; Crystallography, X-Ray; Drug Evaluation, Preclinical; Heterocyclic Compounds, 4 or More Rings; Humans; Indole Alkaloids; Indolizines; Lactams; Molecular Structure; Phenylephrine; Pyrans; Pyridines; Rats; Secologanin Tryptamine Alkaloids; Vasodilator Agents | 2015 |